Income Taxes - Computation of (Benefit) Provision of Income Taxes Reconciliation (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
[1] | Jun. 30, 2024 |
[1] | Mar. 31, 2024 |
[1] | Sep. 30, 2023 |
[1] | Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2024 |
[1] | Jun. 30, 2023 |
Sep. 30, 2024 |
[1] | Sep. 30, 2023 |
[1] | Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||
| Income tax benefit at federal statutory rate | $ (16,024) | $ (11,889) | |||||||||||||||||||
| State and local income taxes, net of federal benefit on current year earnings | 68 | 154 | |||||||||||||||||||
| Tax rate changes | 0 | (1,255) | |||||||||||||||||||
| Valuation allowance changes | 12,345 | 37,283 | |||||||||||||||||||
| Foreign rate differential | (2,454) | (1,665) | |||||||||||||||||||
| Withholding tax on non-permanent investment in subsidiaries | 1,508 | 0 | |||||||||||||||||||
| Research and development | (278) | (2,385) | |||||||||||||||||||
| Share-based compensation | 1,203 | 311 | |||||||||||||||||||
| Foreign derived intangible income | (199) | (2,887) | |||||||||||||||||||
| Return to provision and impact of method change (Federal, State and Foreign) | 2,730 | 0 | |||||||||||||||||||
| Tax expense related to impairment | 25 | 0 | |||||||||||||||||||
| Other | (778) | (199) | |||||||||||||||||||
| Provision (benefit) for income taxes | $ 1,718 | $ 557 | $ 1,928 | $ 15,063 | $ 1,545 | $ (8) | $ 2,485 | $ 1,537 | $ 4,203 | $ 16,600 | $ (1,854) | $ 17,468 | |||||||||
| |||||||||||||||||||||
| X | ||||||||||
- Definition Income tax reconciliation, return to provision and impact of method change. No definition available.
|
| X | ||||||||||
- Definition Income tax reconciliation withholding tax on non-permanent investment in subsidiaries. No definition available.
|
| X | ||||||||||
- Definition Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|